Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Paperbased Isp Control Group

Research Leaders

8 sponsors active, led by Catholic University of Health and Allied Sciences

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Paperbased Isp Control Group1
  • Ivcaorta Ultrasound1
  • Clinical Assessment1
  • Rhapsode Capable Platform Intervention Group1
  • Serial Weights1

Active Sponsors

  • Catholic University of Health and Allied Sciences1
  • National Institutes of Health (NIH)1
  • Bakirkoy Dr. Sadi Konuk Research and Training Hospital1
  • Stanford University1
  • International Centre for Diarrhoeal Disease Research, Bangladesh1

Top Investigators

Related Conditions

  • Simulation Training1
  • Computerassisted Instruction1
  • Inservice Training1
  • Nausea1
  • Severe Pneumonia1

Activity Timeline